CTRG B09/00 A phase I/II study of weekly paclitaxel, UFT, and leucovorin in patients with metastatic breast cancer

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12605000464662

Enrollment

Registered

2005-09-23

Start date

2001-08-06

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Paclitaxel, UFT and Leucovorin, days 1,8 and 15 every 4 weeks, until disease progression or clinical decision.

Study design

Allocation

Non-randomised trial

Intervention model

Single group

Primary purpose

Treatment

Masking

Open (masking not used)

Eligibility

Sex/Gender

All

Age

0 to No maximum

Healthy volunteers

Inclusion criteria

First line metastatic, female, adequate haematological, renal and hepatic function.

Exclusion criteria

No exclusion criteria

Outcome results